Metastatic colorectal cancer treatment: Second National Multidisciplinary Workshop

The treatment of metastatic colorectal cancer has made significant progress in the last ten years, from a uniformly applied surgical

and chemotherapeutic management to the introduction of biological therapy to biomarker testing and thus individualization of care.

There have also been considerable advances in the resection techniques and a major shift towards modern methods of converting a

re-resectable finding of liver metastases to a resectable one. The treatment of a patient with metastatic colorectal cancer (mCRC) is no

longer only in the hands of an experienced oncologist, but rather is an individualized strategy decided upon and reappraised in the

course of the treatment by an interdisciplinary team. It includes not only oncologists and surgeons, but also radiologists, pathologists,

gastroenterologists or other specialists involved in the management of concomitant diseases and side effects of treatment.

Keywords: metastatic colorectal cancer, resectability of liver metastases, interdisciplinary team, treatment personalization, case report